Dual Antiplatelet Therapy Can Be Discontinued at Three Months after Implantation of Zotarolimus-Eluting Stent in Patients with Coronary Artery Disease

<table>Incidences of bleeding events in the 3- and 12-month DAPT groups. DAPT: dual antiplatelet therapy; NS: not significant.</table>

International Scholarly Research Notices

fig2

Figure 2

Figure 2: Dual Antiplatelet Therapy Can Be Discontinued at Three Months after Implantation of Zotarolimus-Eluting Stent in Patients with Coronary Artery Disease 

Figure 2 | Dual Antiplatelet Therapy Can Be Discontinued at Three Months after Implantation of Zotarolimus-Eluting Stent in Patients with Coronary Artery Disease 